Goodwill of Fresenius Medical Care AG from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
ifrs-full: EUR
Summary
Fresenius Medical Care AG quarterly Goodwill in EUR history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Fresenius Medical Care AG Goodwill for the quarter ending 31 Dec 2025 was €13,571,394,000, a 11% decline year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (EUR)
Goodwill, YoY Quarterly Change (%)

Fresenius Medical Care AG Quarterly Goodwill (EUR)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 €13,571,394,000 -€1,599,258,000 -11% 31 Dec 2025 20-F 24 Feb 2026 2025 FY
Q3 2025 €13,585,362,000 -€641,790,000 -4.5% 30 Sep 2025 6-K 04 Nov 2025 2025 Q3
Q2 2025 €13,620,743,000 -€1,186,561,000 -8% 30 Jun 2025 6-K 05 Aug 2025 2025 Q2
Q1 2025 €14,644,789,000 -€30,741,000 -0.21% 31 Mar 2025 6-K 06 May 2025 2025 Q1
Q4 2024 €15,170,652,000 +€520,644,000 +3.6% 31 Dec 2024 20-F 24 Feb 2026 2025 FY
Q3 2024 €14,227,152,000 -€1,180,127,000 -7.7% 30 Sep 2024 6-K 05 Nov 2024 2024 Q3
Q2 2024 €14,807,304,000 -€615,969,000 -4% 30 Jun 2024 6-K 30 Jul 2024 2024 Q2
Q1 2024 €14,675,530,000 -€802,871,000 -5.2% 31 Mar 2024 6-K 07 May 2024 2024 Q1
Q4 2023 €14,650,008,000 -€1,141,173,000 -7.2% 31 Dec 2023 20-F 25 Feb 2025 2024 FY
Q3 2023 €15,407,279,000 -€1,779,828,000 -10% 30 Sep 2023 6-K 02 Nov 2023 2023 Q3
Q2 2023 €15,423,273,000 -€167,403,000 -1.1% 30 Jun 2023 6-K 02 Aug 2023 2023 Q2
Q1 2023 €15,478,401,000 +€849,692,000 +5.8% 31 Mar 2023 6-K 09 May 2023 2023 Q1
Q4 2022 €15,791,181,000 +€1,429,604,000 +10% 31 Dec 2022 20-F 20 Feb 2024 2023 FY
Q3 2022 €17,187,107,000 +€3,285,668,000 +24% 30 Sep 2022 6-K 31 Oct 2022 2022 Q3
Q2 2022 €15,590,676,000 +€2,095,163,000 +16% 30 Jun 2022 6-K 02 Aug 2022 2022 Q2
Q1 2022 €14,628,709,000 +€989,797,000 +7.3% 31 Mar 2022 6-K 04 May 2022 2022 Q1
Q4 2021 €14,361,577,000 +€1,402,849,000 +11% 31 Dec 2021 20-F 22 Feb 2023 2022 FY
Q3 2021 €13,901,439,000 +€312,145,000 +2.3% 30 Sep 2021 6-K 02 Nov 2021 2021 Q3
Q2 2021 €13,495,513,000 -€564,692,000 -4% 30 Jun 2021 6-K 30 Jul 2021 2021 Q2
Q1 2021 €13,638,912,000 -€619,070,000 -4.3% 31 Mar 2021 6-K 06 May 2021 2021 Q1
Q4 2020 €12,958,728,000 -€1,058,527,000 -7.6% 31 Dec 2020 20-F 22 Feb 2022 2021 FY
Q3 2020 €13,589,294,000 -€532,027,000 -3.8% 30 Sep 2020 6-K 29 Oct 2020 2020 Q3
Q2 2020 €14,060,205,000 +€561,582,000 +4.2% 30 Jun 2020 6-K 30 Jul 2020 2020 Q2
Q1 2020 €14,257,982,000 +€696,043,000 +5.1% 31 Mar 2020 6-K 06 May 2020 2020 Q1
Q4 2019 €14,017,255,000 +€1,807,649,000 +15% 31 Dec 2019 20-F 23 Feb 2021 2020 FY
Q3 2019 €14,121,321,000 +€2,138,305,000 +18% 30 Sep 2019 6-K 31 Oct 2019 2019 Q3
Q2 2019 €13,498,623,000 +€1,691,839,000 +14% 30 Jun 2019 6-K 30 Jul 2019 2019 Q2
Q1 2019 €13,561,939,000 +€1,727,355,000 +15% 31 Mar 2019 6-K 02 May 2019 2019 Q1
Q4 2018 €12,209,606,000 +€105,685,000 +0.87% 31 Dec 2018 20-F 20 Feb 2020 2019 FY
Q3 2018 €11,983,016,000 30 Sep 2018 6-K 30 Oct 2018 2018 Q3
Q2 2018 €11,806,784,000 30 Jun 2018 6-K 01 Aug 2018 2018 Q2
Q1 2018 €11,834,584,000 31 Mar 2018 6-K 03 May 2018 2018 Q1
Q4 2017 €12,103,921,000 -€851,653,000 -6.6% 31 Dec 2017 20-F 20 Feb 2019 2018 Q4
Q4 2016 €12,955,574,000 31 Dec 2016 20-F 27 Feb 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.